Surgery Websites
Department of Surgery »  Faculty »  General Surgery »  Cheryl A. Ewing, M.D.
Cheryl A. Ewing, M.D.

Cheryl A. Ewing, M.D.

Professor of Surgery
Division of General Surgery

Contact Information

Academic Office
415) 353-7908
(415) 353-9571
Open Popup
  • 1978-83, Wayne State University School of Medicine, MD
  • 1983-88, St. Joseph Mercy Hospital, University of Michigan Medical School
  • 1988-91, Surgical Oncology Fellow, University of Chicago
  • 1984, American Board of Surgery
  • 1998, American Board of Surgery
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • Ductal Carcinoma In Situ (DCIS)
  • Minority Health
  • Mastectomy
  • Sentinel Lymph Node Biopsy

Dr. Cheryl Ewing is Professor of Surgery at UCSF Mount Zion Hospital.  Her focus is in breast cancer surgery and sentinel lymph node dissection.  Her other interests include quality of care and evaluation of barriers to medical and breast care for minority women.  

Dr. Ewing completed her undergraduate education at the University of Michigan, and received her medical degree from Wayne State University School of Medicine.  She then went on to complete her residency at University of Michigan Medical School, and then her fellowship at the University of Chicago.  She joined the faculty at UCSF in 2001.

Dr. Ewing has lectured extensively at many local, national, and international events.  She has been very active in mentoring residents and fellows, serving four years as the Mount Zion Site Director for the Surgery 110 Rotations and teaching several CME courses and Grand Rounds.  

Dr. Ewing is involved in several studies involving quality of care among breast cancer survivors.  Specifically, these involve post-surgery symptom management, and customizing risk assessment and tailoring treatment to the individual patient's medical profile and preferences.  Her primary focus in on how being a breast cancer survivor affects the quality of life in different race/ethnic groups, and how that relationship is modified by social support, depression, and spirituality.

Dr. Ewing is a member of most of the major surgical societies, and has been the recipient of several awards, including the Susan G. Komen Local Hero Award.

Data provided by UCSF Profiles, powered by CTSI
  1. Abel MK, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Park C, Mukhtar RA. Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2020 Jul 21. View in PubMed
  2. Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater. Am J Surg. 2020 Jun 19. View in PubMed
  3. Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Res Treat. 2020 May; 181(1):23-29. View in PubMed
  4. Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, Mukhtar RA. Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. NPJ Breast Cancer. 2019; 5:29. View in PubMed
  5. Magbanua MJM, Yau C, Wolf DM, Lee JS, Chattopadhyay A, Scott JH, Bowlby-Yoder E, Hwang ES, Alvarado M, Ewing CA, Delson AL, Van't Veer LJ, Esserman L, Park JW. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer. Clin Cancer Res. 2019 09 01; 25(17):5388-5397. View in PubMed
  6. View All Publications


Site Directory